Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
() -- VYNE Therapeutics (VYNE) on Friday declared a special cash dividend estimated at $16.5 million, or about $0.38 per share, in connection with its pending merger with Yarrow Bioscience. The dividend will be payable to shareholders and warrant holders of record as of July 22, with funds expected to be paid to VYNE's
VYNE Therapeutics announced that its board of directors has declared a special cash dividend in connection with the previously announced merger with Yarrow Bioscience, pursuant to the agreement and plan of merger and reorganization, dated December 17, 2025. The cash dividend, which VYNE estimates will be an aggregate o